69 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Tuesday’s Close
PACB Pacific Biosciences of California, Inc. $5.14 $678.18M Uptrend
Article Searches
Why Is Pacific Biosciences (PACB) Down 6.7% Since its Last Earnings Report? http://www.zacks.com/stock/news/306116/why-is-pacific-biosciences-pacb-down-67-since-its-last-earnings-report?cid=CS-ZC-FT-306116 Jun 01, 2018 - Pacific Biosciences (PACB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
The Clock Is Ticking Louder As PacBio Must Generate More Revenue And Shrink Its Cash Burn Rate https://seekingalpha.com/article/4174159-clock-ticking-louder-pacbio-must-generate-revenue-shrink-cash-burn-rate?source=feed_sector_healthcare May 15, 2018 - PacBio's first quarter revenue miss was disappointing, and particularly the sharp reversal in the growth trend of consumables revenue. More and more is riding on the 8M ZMW SMRT cell release late in 2
Here's Why Pacific Biosciences of California Is Falling Today https://www.fool.com/investing/2018/05/03/heres-why-pacific-biosciences-of-california-is-fal.aspx?source=iedfolrf0000001 May 03, 2018 - Disappointing quarterly results weighed on the stock.
For Pacific Biosciences of California, a First Quarter Hurt by Shipment Delays https://www.fool.com/investing/2018/05/03/premium-for-pacific-biosciences-of-california-a-fi.aspx?source=iedfolrf0000001 May 03, 2018 - The gene-sequencing company received plenty of orders for its Sequel systems in the first quarter, but customers weren't ready for most of them.
Pacific Biosciences (PACB) Loss Wider Than Expected in Q1 http://www.zacks.com/stock/news/302183/pacific-biosciences-pacb-loss-wider-than-expected-in-q1?cid=CS-ZC-FT-302183 May 03, 2018 - Pacific Biosciences (PACB) Q1 earnings and revenues miss estimates; Sequel orders rise.
Pacific Biosciences of California's (PACB) CEO Mike Hunkapiller on Q1 2018 Results - Earnings Call Transcript https://seekingalpha.com/article/4168882-pacific-biosciences-californias-pacb-ceo-mike-hunkapiller-q1-2018-results-earnings-call?source=feed_sector_healthcare May 02, 2018 - Pacific Biosciences of California Inc. (NASDAQ:PACB) Q1 2018 Earnings Conference Call May 02, 2018 04:30 PM ET Executives Trevin Rard - Investor Relations Mike Hunkapiller - Chief Executive Officer Su
After-Hours Report: NSIT +26%, SFS +7%, PACB -18%, SPOT -7%, CERN -6.2% following earnings/guidance: http://www.briefing.com/investor/popuppages/articlepopup.aspx?articleId=NS20180502171819AfterHoursReport May 02, 2018 - The major averages finished the midweek session on a lower note despite an upbeat quarterly earnings
Can Core Unit Drive Pacific Biosciences' (PACB) Q1 Earnings? http://www.zacks.com/stock/news/299887/can-core-unit-drive-pacific-biosciences-pacb-q1-earnings?cid=CS-ZC-FT-299887 Apr 19, 2018 - Pacific Biosciences gains ground on solid Sequel Growth, while shrinking service revenues raise concern.
Pacific Biosciences Gains as HudsonAlpha Picks Sequel System http://www.zacks.com/stock/news/299041/pacific-biosciences-gains-as-hudsonalpha-picks-sequel-system?cid=CS-ZC-FT-299041 Apr 12, 2018 - Pacific Biosciences (PACB) sees increasing use of Sequel Sequencing System in pediatric and plant biologic case studies.
Pacific Biosciences: A Shovel Supplier To The Genomics Megatrend https://seekingalpha.com/article/4162207-pacific-biosciences-shovel-supplier-genomics-megatrend?source=feed_sector_healthcare Apr 10, 2018 - Pacific Biosciences of California is one of the main three producers of genome sequencing machines, alongside Illumina and privately-held Oxford Nanopore Technologies.Anecdotal support for PACB out of

Pages: 1234567

<Page 2>